Publication Name	World Journal of Hepatology
Manuscript ID	89202
Country	China

Received	2023-10-23 15:13
Peer-Review Started	2023-10-23 15:14
To Make the First Decision
Return for Revision	2023-11-22 23:34
Revised	2023-11-27 08:40
Second Decision	2023-12-05 09:08
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-12-12 07:54
Articles in Press	2023-12-12 07:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-12-15 06:34
Publish the Manuscript Online	2023-12-25 06:03

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
Manuscript Source	Invited Manuscript
All Author List	Li Chen
ORCID	Author(s) ORCID Number Li Chen http://orcid.org/0000-0001-8492-1963
Funding Agency and Grant Number
Corresponding Author	Li Chen, Doctor, MD, PhD, Doctor, Department of Gastroenterology, Ruijin Hospital , Shanghai JiaoTong University, School of Medicine, No. 999 Xiwang Road, Jiading District, Shanghai 201801, China. drchenli@163.com
Key Words	Non-alcoholic fatty liver disease; Metabolic dysfunction-associated fatty liver disease; Metabolic dysfunction-associated steatotic liver disease; Nomenclature; Metabolic risk factors
Core Tip	The nomenclature for non-alcoholic fatty liver disease has undergone name changes twice in a span of three years. However, there exist significant disparities and some consensus between the transition from metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease. Clarifying these discrepancies would greatly benefit clinical practice and trials.
Publish Date	2023-12-25 06:03
Citation	Chen L. From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus. World J Hepatol 2023; 15(12): 1253-1257
URL	https://www.wjgnet.com/1948-5182/full/v15/i12/1253.htm
DOI	https://dx.doi.org/10.4254/wjh.v15.i12.1253

Full Article (PDF)	WJH-15-1253-with-cover.pdf
Full Article (Word)	WJH-15-1253.docx
Manuscript File	89202_Auto_Edited-LJH-YJP.docx
Answering Reviewers	89202-Answering reviewers.pdf
Audio Core Tip	89202-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	89202-Conflict-of-interest statement.pdf
Copyright License Agreement	89202-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	89202-Language certificate.pdf
Peer-review Report	89202-Peer-review(s).pdf
Scientific Misconduct Check	89202-Bing-Liu JH-2.png
Scientific Misconduct Check	89202-CrossCheck.png
Scientific Editor Work List	89202-Scientific editor work list.pdf